▶ 調査レポート

世界の壊死性筋膜炎市場：市場規模・現状・予測
• 英文タイトル：Global Necrotizing Fasciitis Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の壊死性筋膜炎市場：市場規模・現状・予測 / Global Necrotizing Fasciitis Market Size, Status and Forecast 2019-2025 / QYR9N7636資料のイメージです。• レポートコード：QYR9N7636
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、壊死性筋膜炎のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII、タイプⅢ）、用途別（病院と診療所、手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・壊死性筋膜炎の世界市場規模
・主要企業別市場シェア
・壊死性筋膜炎の世界市場規模：種類別（タイプI、タイプII、タイプⅢ）
・壊死性筋膜炎の世界市場規模：用途別（病院と診療所、手術センター）
・壊死性筋膜炎のアメリカ市場規模（種類別、用途別）
・壊死性筋膜炎のヨーロッパ市場規模（種類別、用途別）
・壊死性筋膜炎の中国市場規模（種類別、用途別）
・壊死性筋膜炎の日本市場規模（種類別、用途別）
・壊死性筋膜炎の東南アジア市場規模（種類別、用途別）
・壊死性筋膜炎のインド市場規模（種類別、用途別）
・壊死性筋膜炎の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・壊死性筋膜炎の世界市場予測（2019年-2025年）
・壊死性筋膜炎の地域別市場予測（2019年-2025年）
...

Necrotizing fasciitis (NF), commonly known as flesh-eating disease, is an infection that results in the death of the body’s soft tissue. It is a severe disease of sudden onset that spreads rapidly. Symptoms include red or purple skin in the affected area, severe pain, fever, and vomiting. The most commonly affected areas are the limbs and perineum.Necrotizing fasciitis affects 0.4 to 1.0 person per 100,000 per year. Both sexes are affected equally. It becomes more common among older people and is very rare in children. Surgical debridement (cutting away affected tissue) is the mainstay of treatment for necrotizing fasciitis. Early medical treatment is often presumptive; thus, antibiotics should be started as soon as this condition is suspected. Cultures are taken to determine appropriate antibiotic coverage, and antibiotics may be changed when culture results are obtained. Besides blood pressure control and hydration, support should be initiated for those with unstable vital signs and low urine output.
In 2018, the global Necrotizing Fasciitis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Necrotizing Fasciitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Necrotizing Fasciitis development in United States, Europe and China.

The key players covered in this study
Merck
Wockhardt
Atox Bio
Teva Pharmaceutical Industries
Basilea Pharmaceutica
Melinta Therapeutics
…

Market segment by Type, the product can be split into
Type I
Type II
Type III

Market segment by Application, split into
Hospital & Clinics
Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Necrotizing Fasciitis status, future forecast, growth opportunity, key market and key players.
To present the Necrotizing Fasciitis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Necrotizing Fasciitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Necrotizing Fasciitis Market Size Growth Rate by Type (2014-2025)
1.4.2 Type I
1.4.3 Type II
1.4.4 Type III
1.5 Market by Application
1.5.1 Global Necrotizing Fasciitis Market Share by Application (2014-2025)
1.5.2 Hospital & Clinics
1.5.3 Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Necrotizing Fasciitis Market Size
2.2 Necrotizing Fasciitis Growth Trends by Regions
2.2.1 Necrotizing Fasciitis Market Size by Regions (2014-2025)
2.2.2 Necrotizing Fasciitis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Necrotizing Fasciitis Market Size by Manufacturers
3.1.1 Global Necrotizing Fasciitis Revenue by Manufacturers (2014-2019)
3.1.2 Global Necrotizing Fasciitis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Necrotizing Fasciitis Market Concentration Ratio (CR5 and HHI)
3.2 Necrotizing Fasciitis Key Players Head office and Area Served
3.3 Key Players Necrotizing Fasciitis Product/Solution/Service
3.4 Date of Enter into Necrotizing Fasciitis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Necrotizing Fasciitis Market Size by Type (2014-2019)
4.2 Global Necrotizing Fasciitis Market Size by Application (2014-2019)

5 United States
5.1 United States Necrotizing Fasciitis Market Size (2014-2019)
5.2 Necrotizing Fasciitis Key Players in United States
5.3 United States Necrotizing Fasciitis Market Size by Type
5.4 United States Necrotizing Fasciitis Market Size by Application

6 Europe
6.1 Europe Necrotizing Fasciitis Market Size (2014-2019)
6.2 Necrotizing Fasciitis Key Players in Europe
6.3 Europe Necrotizing Fasciitis Market Size by Type
6.4 Europe Necrotizing Fasciitis Market Size by Application

7 China
7.1 China Necrotizing Fasciitis Market Size (2014-2019)
7.2 Necrotizing Fasciitis Key Players in China
7.3 China Necrotizing Fasciitis Market Size by Type
7.4 China Necrotizing Fasciitis Market Size by Application

8 Japan
8.1 Japan Necrotizing Fasciitis Market Size (2014-2019)
8.2 Necrotizing Fasciitis Key Players in Japan
8.3 Japan Necrotizing Fasciitis Market Size by Type
8.4 Japan Necrotizing Fasciitis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Necrotizing Fasciitis Market Size (2014-2019)
9.2 Necrotizing Fasciitis Key Players in Southeast Asia
9.3 Southeast Asia Necrotizing Fasciitis Market Size by Type
9.4 Southeast Asia Necrotizing Fasciitis Market Size by Application

10 India
10.1 India Necrotizing Fasciitis Market Size (2014-2019)
10.2 Necrotizing Fasciitis Key Players in India
10.3 India Necrotizing Fasciitis Market Size by Type
10.4 India Necrotizing Fasciitis Market Size by Application

11 Central & South America
11.1 Central & South America Necrotizing Fasciitis Market Size (2014-2019)
11.2 Necrotizing Fasciitis Key Players in Central & South America
11.3 Central & South America Necrotizing Fasciitis Market Size by Type
11.4 Central & South America Necrotizing Fasciitis Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Necrotizing Fasciitis Introduction
12.1.4 Merck Revenue in Necrotizing Fasciitis Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Wockhardt
12.2.1 Wockhardt Company Details
12.2.2 Company Description and Business Overview
12.2.3 Necrotizing Fasciitis Introduction
12.2.4 Wockhardt Revenue in Necrotizing Fasciitis Business (2014-2019)
12.2.5 Wockhardt Recent Development
12.3 Atox Bio
12.3.1 Atox Bio Company Details
12.3.2 Company Description and Business Overview
12.3.3 Necrotizing Fasciitis Introduction
12.3.4 Atox Bio Revenue in Necrotizing Fasciitis Business (2014-2019)
12.3.5 Atox Bio Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Company Details
12.4.2 Company Description and Business Overview
12.4.3 Necrotizing Fasciitis Introduction
12.4.4 Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2014-2019)
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 Basilea Pharmaceutica
12.5.1 Basilea Pharmaceutica Company Details
12.5.2 Company Description and Business Overview
12.5.3 Necrotizing Fasciitis Introduction
12.5.4 Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2014-2019)
12.5.5 Basilea Pharmaceutica Recent Development
12.6 Melinta Therapeutics
12.6.1 Melinta Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Necrotizing Fasciitis Introduction
12.6.4 Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2014-2019)
12.6.5 Melinta Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Necrotizing Fasciitis Key Market Segments
Table Key Players Necrotizing Fasciitis Covered
Table Global Necrotizing Fasciitis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Necrotizing Fasciitis Market Size Market Share by Type 2014-2025
Figure Type I Figures
Table Key Players of Type I
Figure Type II Figures
Table Key Players of Type II
Figure Type III Figures
Table Key Players of Type III
Table Global Necrotizing Fasciitis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital & Clinics Case Studies
Figure Surgical Centers Case Studies
Figure Necrotizing Fasciitis Report Years Considered
Table Global Necrotizing Fasciitis Market Size 2014-2025 (Million US$)
Figure Global Necrotizing Fasciitis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Necrotizing Fasciitis Market Size by Regions 2014-2025 (Million US$)
Table Global Necrotizing Fasciitis Market Size by Regions 2014-2019 (Million US$)
Table Global Necrotizing Fasciitis Market Share by Regions 2014-2019
Figure Global Necrotizing Fasciitis Market Share by Regions 2014-2019
Figure Global Necrotizing Fasciitis Market Share by Regions 2019
Table Market Top Trends
Table Global Necrotizing Fasciitis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Necrotizing Fasciitis Market Share by Manufacturers (2014-2019)
Figure Global Necrotizing Fasciitis Market Share by Manufacturers in 2018
Table Global Necrotizing Fasciitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Necrotizing Fasciitis Product/Solution/Service
Table Date of Enter into Necrotizing Fasciitis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table Global Necrotizing Fasciitis Market Size Share by Type (2014-2019)
Figure Global Necrotizing Fasciitis Market Size Market Share by Type (2014-2019)
Table Global Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table Global Necrotizing Fasciitis Market Size Share by Application (2014-2019)
Figure Global Necrotizing Fasciitis Market Size Market Share by Application (2014-2019)
Figure Global Necrotizing Fasciitis Revenue Market Share by Application in 2018
Figure United States Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table United States Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table United States Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table United States Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table United States Necrotizing Fasciitis Market Share by Type (2014-2019)
Table United States Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table United States Necrotizing Fasciitis Market Share by Application (2014-2019)
Figure Europe Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table Europe Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table Europe Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table Europe Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table Europe Necrotizing Fasciitis Market Share by Type (2014-2019)
Table Europe Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table Europe Necrotizing Fasciitis Market Share by Application (2014-2019)
Figure China Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table China Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table China Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table China Necrotizing Fasciitis Market Size by Type (2014-20189) (Million US$)
Table China Necrotizing Fasciitis Market Share by Type (2014-2019)
Table China Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table China Necrotizing Fasciitis Market Share by Application (2014-2019)
Figure Japan Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table Japan Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table Japan Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table Japan Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table Japan Necrotizing Fasciitis Market Share by Type (2014-2019)
Table Japan Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table Japan Necrotizing Fasciitis Market Share by Application (2014-2019)
Figure Southeast Asia Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table Southeast Asia Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Necrotizing Fasciitis Market Share by Type (2014-2019)
Table Southeast Asia Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Necrotizing Fasciitis Market Share by Application (2014-2019)
Figure India Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table India Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table India Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table India Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table India Necrotizing Fasciitis Market Share by Type (2014-2019)
Table India Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table India Necrotizing Fasciitis Market Share by Application (2014-2019)
Figure Central & South America Necrotizing Fasciitis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Necrotizing Fasciitis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Necrotizing Fasciitis Market Share (2018-2019)
Table Central & South America Necrotizing Fasciitis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Necrotizing Fasciitis Market Share by Type (2014-2019)
Table Central & South America Necrotizing Fasciitis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Necrotizing Fasciitis Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Necrotizing Fasciitis Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Necrotizing Fasciitis Business (2014-2019)
Table Merck Recent Development
Table Wockhardt Company Details
Table Wockhardt Revenue in Necrotizing Fasciitis Business (2014-2019)(Million US$)
Figure Wockhardt Revenue Growth Rate in Necrotizing Fasciitis Business (2014-2019)
Table Wockhardt Recent Development
Table Atox Bio Company Details
Table Atox Bio Revenue in Necrotizing Fasciitis Business (2014-2019)(Million US$)
Figure Atox Bio Revenue Growth Rate in Necrotizing Fasciitis Business (2014-2019)
Table Atox Bio Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Necrotizing Fasciitis Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Basilea Pharmaceutica Company Details
Table Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2014-2019)(Million US$)
Figure Basilea Pharmaceutica Revenue Growth Rate in Necrotizing Fasciitis Business (2014-2019)
Table Basilea Pharmaceutica Recent Development
Table Melinta Therapeutics Company Details
Table Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2014-2019)(Million US$)
Figure Melinta Therapeutics Revenue Growth Rate in Necrotizing Fasciitis Business (2014-2019)
Table Melinta Therapeutics Recent Development
Table Global Necrotizing Fasciitis Market Size by Regions (Million US$) 2019-2025
Figure Global Necrotizing Fasciitis Market Size Share by Regions (2019-2025)
Figure Global Necrotizing Fasciitis Market Size Share by Regions in 2025
Figure United States Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Figure China Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Figure India Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Necrotizing Fasciitis Market Size Forecast (2019-2025)(Million USD)
Table Global Necrotizing Fasciitis Market Size by Product (2019-2025) (Million US$)
Figure Global Necrotizing Fasciitis Market Size by Product (2019-2025)
Figure Global Necrotizing Fasciitis Market Size by Product in 2025
Table Global Necrotizing Fasciitis Market Size by Application (2019-2025) (Million US$)
Figure Global Necrotizing Fasciitis Market Size by Application (2019-2025)
Figure Global Necrotizing Fasciitis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の強膜炎市場：市場規模・現状・予測
    Global Scleritis Market Size, Status and Forecast 2019-2025
    QYR9N8001 2019年6月14日 97Pages
    当資料は、強膜炎のグローバル市場について調査・分析したレポートで、種類別（びまん性前部強膜炎、結節性前部強膜炎、壊死性前部強膜炎、後部強膜炎）、用途別（病院、診療所、家庭、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...
  • 世界のロミプロスチム市場：市場規模・現状・予測
    Global Romiplostim Market Size, Status and Forecast 2019-2025
    QYR9N7982 2019年6月14日 92Pages
    当資料は、ロミプロスチムのグローバル市場について調査・分析したレポートで、種類別（250 μg/0.5 mL
    、500 μg/1 mL
    ）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測
    Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
    QYR9N8229 2019年6月14日 97Pages
    当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の光原子時計市場：市場規模・現状・予測
    Global Optical Atomic Clocks Market Size, Status and Forecast 2019-2025
    QYR9N7711 2019年6月14日 92Pages
    当資料は、光原子時計のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（地上アプリケーション、宇宙アプリケーション）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界のラパチニブ市場：市場規模・現状・予測
    Global Lapatinib Market Size, Status and Forecast 2019-2025
    QYR9N7436 2019年6月14日 98Pages
    当資料は、ラパチニブのグローバル市場について調査・分析したレポートで、種類別（250 mg錠、タイプII）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・...
  • 世界のエクセナチド市場：市場規模・現状・予測
    Global Exenatide Market Size, Status and Forecast 2019-2025
    QYR9N7180 2019年6月14日 94Pages
    当資料は、エクセナチドのグローバル市場について調査・分析したレポートで、種類別（持続放出注射懸濁液、速放注射懸濁液）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の量子コンピュータ市場：市場規模・現状・予測
    Global Quantum Computers Market Size, Status and Forecast 2019-2025
    QYR9N7916 2019年6月14日 99Pages
    当資料は、量子コンピュータのグローバル市場について調査・分析したレポートで、種類別（ゲートレベル、量子アニーリング）、用途別（計算化学、機械学習、財務の最適化、物流とスケジューリング、ドラッグデザイン、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...
  • 世界のレタパムリン市場：市場規模・現状・予測
    Global Retapamulin Market Size, Status and Forecast 2019-2025
    QYR9N7962 2019年6月14日 92Pages
    当資料は、レタパムリンのグローバル市場について調査・分析したレポートで、種類別（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界のA2Pメッセージング市場：市場規模・現状・予測
    Global A2P Messaging Market Size, Status and Forecast 2019-2025
    QYR9N8232 2019年6月14日 92Pages
    当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...
  • 世界のプレリキサフォル市場：市場規模・現状・予測
    Global Plerixafor Market Size, Status and Forecast 2019-2025
    QYR9N7839 2019年6月14日 93Pages
    当資料は、プレリキサフォルのグローバル市場について調査・分析したレポートで、種類別（24MG / 1.2ML、タイプII）、用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の強膜炎市場：市場規模・現状・予測世界の強膜炎市場：市場規模・現状・予測 Sclera is the outer layer of the eye. Scleritis is a disorder in which the sclera severely becomes red and inflamed.Globally North America is the largest market for Scleritis. Europe is the second-largest market and Asia Pacific is expected to grow at a rapid rate. In 2018, the global Scleritis mark…
  • 世界の画像誘導およびロボット支援外科手術市場：市場規模・現状・予測世界の画像誘導およびロボット支援外科手術市場：市場規模・現状・予測 Robotic surgery is usually associated with minimally invasive surgery — procedures performed through tiny incisions. It is also sometimes used in certain traditional open surgical procedures.Rise in spending on medical equipment by hospitals is expected to boost the penetration of image-guided and r…
  • 世界の外来診療所市場：市場規模・現状・予測世界の外来診療所市場：市場規模・現状・予測 The outpatient clinics has continued to play a significant role in management of the cognitive behavioral disorders. High-risk situations such as substance abuse, sexual offence, depression, obesity and obsessive-compulsive behavior is becoming a major concern in various countries. Management of hig…
  • 世界の肺胞蛋白症（PAP）市場：市場規模・現状・予測世界の肺胞蛋白症（PAP）市場：市場規模・現状・予測 Pulmonary alveolar proteinosis (PAP), also known as pulmonary alveolar phospholipoproteinosis, is a diffuse lung disease characterized by the accumulation of amorphous, periodic acid-Schiff (PAS)-positive lipoproteinaceous material in the distal air spaces.Treatment of PAP depends on the form of PAP…
  • 世界の非外科外側上顆炎治療市場：市場規模・現状・予測世界の非外科外側上顆炎治療市場：市場規模・現状・予測 The non surgical treatment includes extracorporeal shock wave therapy, braces, medications and physical therapies. Various anti inflammatory drugs (NSAIDS) such as ibuprofen, aspirin and cortisone are administered to control pain in lateral epicondylitis. In 2018, the global Non-surgical Lateral Epi…